Introduction {#section1-1403494818799613}
============

Denmark is a small country with 5,800,000 inhabitants \[[@bibr1-1403494818799613]\] and a universal free healthcare system. Despite this, disparities in socioeconomic status and health-related factors according to geographical location are evident \[[@bibr2-1403494818799613]\]. Lolland and Falster are two southern islands with a mixed rural-provincial population of 103,000 inhabitants \[[@bibr3-1403494818799613]\]. Lolland Municipality consists of the Western part of Lolland, whereas Guldborgsund Municipality consists of the Eastern part of Lolland and Falster ([Figure 1](#fig1-1403494818799613){ref-type="fig"}). The Lolland-Falster population is less educated \[[@bibr4-1403494818799613]\], has a lower income \[[@bibr5-1403494818799613]\], has more people outside the workforce \[[@bibr6-1403494818799613]\] and, especially on Lolland, more people move out of the area than into it \[[@bibr7-1403494818799613]\]. Average life expectancy in Denmark overall is presently 80.8 years, but only 78.5 years in Guldborgsund Municipality and 77.3 years in Lolland Municipality \[[@bibr8-1403494818799613]\].

![Map of Denmark with Lolland-Falster marked. Lolland Municipality in red and Guldborgsund Municipality in grey. Nakskov, Maribo and Nykøbing Falster are shown. Lolland is the island to the left and Falster is the island to the right. Lolland Municipality consists of the Western part of Lolland, whereas Guldborgsund Municipality consists of the Eastern part of Lolland and Falster.](10.1177_1403494818799613-fig1){#fig1-1403494818799613}

Low socioeconomic status is associated with underlying adverse health outcomes in children as well as adults \[[@bibr9-1403494818799613][@bibr10-1403494818799613][@bibr11-1403494818799613][@bibr12-1403494818799613][@bibr13-1403494818799613]--[@bibr14-1403494818799613]\]. Correspondingly, the inhabitants of Lolland-Falster have reported a high burden of physical and mental health problems, a high prevalence of unhealthy lifestyle factors, and lack of contact with friends and family in the recently published questionnaire-based Health Profile 2017 \[[@bibr15-1403494818799613]\]. The health and well-being of children and adults on Lolland-Falster are thus of public health concern.

This has formed the background for the Lolland-Falster Health Study (LOFUS). The study is organized as a large-scale household-based prospective cohort study with self-reported questionnaires, physical examinations, biological samples and links to Danish registries. It is the expectation that this study can form the basis for research into the causes of the disease burden of the Lolland-Falster population and inform the planning of preventive and health-promoting interventions.

Denmark has a number of ongoing population-based studies, e.g. the Danish Diet, Cancer and Health Study \[[@bibr16-1403494818799613]\], the Copenhagen City Heart Study \[[@bibr17-1403494818799613]\], the Danish General Suburban Population Study \[[@bibr18-1403494818799613]\], the Copenhagen General Population Study \[[@bibr18-1403494818799613]\], and the Danish National Birth Cohort \[[@bibr20-1403494818799613]\]. However, it is a unique feature of LOFUS to focus in the mixed rural-provincial part of the Danish population and to include entire household members as study participants. From a public health perspective, it is important to investigate diverse populations to avoid selection bias and to enhance generalizability.

Objectives {#section2-1403494818799613}
----------

The primary aim of LOFUS is to create a scientific resource with a research database and a biobank with the opportunity to investigate cross-sectional differences and longitudinal changes in risk factors and disease burden within and between individuals, families and households. The specific aims are to:

1.  1) identify socioeconomic, hereditary, lifestyle, familial and environmental risk factors;

2.  2) examine family and household patterns in poor health and salutogenic factors;

3.  3) examine interaction between characteristics of the local community and the individual health status;

4.  4) describe time trends in risk factors and disease burden;

5.  5) investigate if time trends in risk factors have an effect on disease burden;

6.  6) identify new risk factors for disease;

7.  7) investigate interactions between risk factors; and

8.  8) with special reference to the biobank part of LOFUS, understand the association between naturally occurring bacteria and pathogens, oxidative stress, metabolic changes and genetic and epigenetic factors in disease occurrence.

Hypothesis {#section3-1403494818799613}
----------

The burden of diseases in the Lolland-Falster population is hypothesized to result from a combination of socioeconomic, genetic, lifestyle-related, familial and environmental factors, and the combination and weight of these factors are expected to differ from the pattern seen in previous studies of populations in the capital and larger cities of Denmark \[[@bibr17-1403494818799613][@bibr18-1403494818799613]--[@bibr19-1403494818799613]\].

Methods and analysis {#section4-1403494818799613}
====================

Study design {#section5-1403494818799613}
------------

LOFUS is a household-based prospective cohort study including two populations: an invited group and an uninvited, non-contacted control group. The data collection for the invited group encompasses questionnaires, physical examinations and collection of biological specimens.

Population {#section6-1403494818799613}
----------

The target population is the 42,084 inhabitants in Lolland Municipality (2017 figures) \[[@bibr21-1403494818799613]\] and 60 979 (2017 figures) inhabitants in Guldborgsund Municipality \[[@bibr22-1403494818799613]\]. Inhabitants of all ages and nationalities are included. Excluded are incapacitated people with guardians, individuals without a permanent residence, inhabitants with address protection and inhabitants unable to understand Danish or English. Enrolment started in February 2016 and will be ongoing until the end of 2019, then planned to reach 20,000 participants.

Invitation and booking procedures {#section7-1403494818799613}
---------------------------------

Almost daily, and adjusted to the current staffing capacity, people aged 18 or above are randomly selected from the Danish Civil Registration System. Their entire households are then randomly allocated to either the invitation or the control group in a 2:1 ratio ([Figure 2](#fig2-1403494818799613){ref-type="fig"}). Only people and addresses not previously invited are eligible for selection. Invitations are sent individually to each member of the invited households. It is mandatory for Danes ⩾15 years to have an electronic personal mailbox (e-box) for messages from public authorities including from the healthcare sector \[[@bibr14-1403494818799613]\]. Therefore, LOFUS invitations are issued via the e-boxes. Inhabitants exempted from e-box and \<15 years receive invitation by ordinary mail. Invited people not responding within two weeks by either email, phone, or text message are re-invited. After a minimum of another two weeks, attempts are made to reach non-responders by phone.

![Population, households and study sample for the Lolland-Falster Health Study. Randomly selected households are randomly allocated to either the invitation group (in grey) or the control group (in white) in a 2:1 ratio.](10.1177_1403494818799613-fig2){#fig2-1403494818799613}

Invited individuals who agree to participate are booked for an appointment and receive a confirmation letter including the link and password to their web-based questionnaire. Members of a household are booked together, if they prefer. LOFUS has three stationary sites: in Nakskov, Maribo, and Nykøbing Falster ([Figure 1](#fig1-1403494818799613){ref-type="fig"}). All sites have an undisturbed room for the dialogue concerning the written informed consent. In Nakskov and Maribo, there is another room for the health examination, whereas the facility in Nykøbing Falster has three such rooms. At booking, participants are free to decide which site to attend. If participants are unable to visit the stationary site, the staff can visit them at home using a fully equipped camper or provide a taxi.

Staff {#section8-1403494818799613}
-----

Certified nurses and biomedical laboratory technicians obtain the written informed consent and perform the health examinations. At employment, the staff undergo a mandatory introduction programme covering standard operation procedures and ethical and communicative aspects of the work. Adherence to procedures is monitored through self-assessment and follow-up by colleagues and management.

Questionnaires {#section9-1403494818799613}
--------------

The LOFUS questionnaires are constructed from a combination of previously used items and scales and new scales developed for the purpose. Five, partially different, questionnaires are used for the age groups 0--1, 2--3, 4--10, 11--17, and ⩾18 years. Key items include self-assessed health and well-being, mental and physical health, relationships and lifestyle factors, [Table I](#table1-1403494818799613){ref-type="table"} for the ⩾18 years' questionnaire. Furthermore, some sub-studies have additional questionnaires for designated subsets of the participants. Participants are recommended to complete the questionnaire electronically at home before attending the health examination. Parents should complete the questionnaire for children ⩽10 years. If needed, the staff can help with completing the questionnaires at the health examination. Paper-based questionnaires are used only when participants cannot master the electronic version.

###### 

Questionnaire in the Lolland-Falster Health Study for participants ⩾18 years.

![](10.1177_1403494818799613-table1)

  ---------------------------------------------------------------------------------------
  **Scale/items**
  Health and well-being
  Mental health
  Self-care
  Diseases
  Pain
  Prescription and over the counter medication
  Diet
  Screen/digital time
  Physical activity
  Transport
  Sleep
  Height and weight
  Smoking
  Pets
  Alcohol and drugs
  Periods, pregnancies and births
  Family and friends
  Life events
  Marital status
  Education and work status
  Personality^[\*](#table-fn1-1403494818799613){ref-type="table-fn"}^
  Contact to healthcare system^[\*](#table-fn1-1403494818799613){ref-type="table-fn"}^
  Work load^[\*](#table-fn1-1403494818799613){ref-type="table-fn"}^
  Ear, nose and throat problems^[\*](#table-fn1-1403494818799613){ref-type="table-fn"}^
  Incontinence in women^[\*](#table-fn1-1403494818799613){ref-type="table-fn"}^
  Frailty and functions^[\*](#table-fn1-1403494818799613){ref-type="table-fn"}^
  Health literacy^[\*](#table-fn1-1403494818799613){ref-type="table-fn"}^
  ---------------------------------------------------------------------------------------

Additional items triggered by response to selected items above.

Health examination {#section10-1403494818799613}
------------------

The health examination includes measurement of anthropometrics, electrocardiography, blood pressure, pulse, oxygen saturation, spirometry, hand grip strength and accelerometer-assessed physical activity. The content of the health examination varies to some extent by age group ([Table II](#table2-1403494818799613){ref-type="table"}). Other examinations may be added by appointment with research collaborators.

###### 

Health examination in the Lolland-Falster Health Study.

![](10.1177_1403494818799613-table2)

  Examination                                                                                    Age (years)                         Equipment
  ---------------------------------------------------------------------------------------------- ----------------------------------- ---------------------------------------------------------------------------------------------------------------------
  Arm blood pressure                                                                             ⩾4                                  Welch Allyn Connex Pro BPO 3400 Electronic blood pressure devise
  Ankle blood pressure^[\*](#table-fn2-1403494818799613){ref-type="table-fn"}^                   ⩾50                                 Welch Allyn Connex Pro BPO 3400 Electronic blood pressure devise and EDAN SD3 Vitrosonic Pocket Doppler 8 MHz probe
  Electrocardiogram                                                                              All                                 GE Healthcare ECG device MAC 5500 HD
  Height                                                                                         All                                 SECA 216 Wall-mounted height measure
  Weight                                                                                         All                                 Tanita Body Composition Analyzer BC-420MA III or Electronic scale Tanita WB 150 SMA
  Waist and hip circumference                                                                    All                                 Tape measure
  Head circumference                                                                             \<4                                 SECA 212 Measuring tape
  Lung function (spirometry)                                                                     ⩾7                                  MicroLab^TM^ and MicroLoop^TM^ Handheld Spirometer with PC Software
  Peripheral oxygen saturation                                                                   All                                 Nellcor^TM^ Portable SpO~2~ Patient Monitoring System, PM10N
  Pulse                                                                                          All                                 Nellcor^TM^ Portable SpO~2~ Patient Monitoring System, PM10N
  Bioimpedance                                                                                   ⩾18                                 Tanita Body Composition Analyzer BC-420MA III
  Hand-grip strength                                                                             ⩾50                                 Seahan digital hand dynamometer
  Electronic accelerometer measurement[\*\*](#table-fn3-1403494818799613){ref-type="table-fn"}   Families with child/children \<18   Axivity AX3 2 × accelerometer

Collected 2016 and 2017.

Collected 2017 and 2018.

Staff collaborate with parents to create a supportive environment for children to comply with the health examination, e.g. confidence is built through play where young children pretend to assist the staff with measuring older siblings or parents.

Biological sample collection, analyses and storage conditions {#section11-1403494818799613}
-------------------------------------------------------------

The biological specimens include blood, urine, saliva and faeces ([Table III](#table3-1403494818799613){ref-type="table"}). Capillary blood is collected from all participants and whole blood from participants ⩾15 years. Urine, saliva and faeces are collected from a subset of participants ([Table III](#table3-1403494818799613){ref-type="table"}). Whole blood samples (38 ml) are drawn in the non-fasting state between 8:40 a.m. and 6:30 p.m. in vacutainer blood collection tubes (Becton, Dickinson and Company; Franklin Lakes, NJ, USA). The 12 ml blood and 4 ml urine samples for same-day biochemical analyses are kept at 21ºC (±4ºC) until delivery at 8:00 p.m. for immediate analysis at the Department of Clinical Biochemistry (Nykøbing Falster Hospital) ([Table III](#table3-1403494818799613){ref-type="table"}). The Departments of Clinical Biochemistry at Nykøbing Falster and Næstved Hospitals (40 km north of Nykøbing Falster) are accredited by the standard ISO 15189, and the Region Zealand Biobank is hosted in Næstved. Assays are followed up daily for precision and several times yearly for accuracy with a Scandinavian quality-control programme.

###### 

Sample preservative, volume and measurements.

![](10.1177_1403494818799613-table3)

  Type of sample                                                     Age, years   Volume collected (ml)                                         Measurements                                                          Type of analyzer
  ------------------------------------------------------------------ ------------ ------------------------------------------------------------- --------------------------------------------------------------------- ------------------------------
  Natrium-citrate                                                    ⩾15          4.5                                                           INR                                                                   STA-R (Stago)
  Lithium-Heparin (PST)                                              ⩾15          3.5                                                           Chemistry[\*](#table-fn5-1403494818799613){ref-type="table-fn"}       Siemens Dimension Vista 1500
  Clot activator (SST)                                               ⩾15          6.0                                                           Biobank-serum                                                         −
  EDTA                                                               ⩾15          2[\*](#table-fn5-1403494818799613){ref-type="table-fn"}10     Biobank plasma and buffy coat                                         −
  EDTA                                                               ⩾15          2.0                                                           Haematology[\*\*](#table-fn6-1403494818799613){ref-type="table-fn"}   Sysmex XE-5000
  EDTA                                                               ⩾15          2.0                                                           HbA1C                                                                 TOSOH-G8
  Finger stick                                                       Any age      −                                                             Plasma Glucose                                                        Bayer Contour XT
  Urine                                                              ⩾15          4                                                             Albumin/creatinine ratio                                              Siemens Dimension Vista 1500
  Urine[\*\*\*](#table-fn7-1403494818799613){ref-type="table-fn"}    ⩾7           2[\*](#table-fn5-1403494818799613){ref-type="table-fn"}4      Biobank                                                               −
  Saliva[\*\*\*](#table-fn7-1403494818799613){ref-type="table-fn"}   ⩾11          3[\*](#table-fn5-1403494818799613){ref-type="table-fn"}1.8    Biobank                                                               −
  Faeces[\*\*\*](#table-fn7-1403494818799613){ref-type="table-fn"}   Any age      3[\*](#table-fn5-1403494818799613){ref-type="table-fn"}2-10   Biobank                                                               −

PST: plasma separation tube; SST: serum separation tube; EDTA: ethylene diamine tetra-acetate; HbAlC: glycated haemoglobin A1c.

Chemistry: iron, transferrin, ferritin, free triiodothyronine (fT3), free thyroxine (fT4), thyroid stimulating hormone (TSH), sodium, potassium, alkaline phosphate, alanine amino transferase, bilirubin, creatinine, total cholesterol, low-density lipoprotein cholesterol (calculated), high-density lipoprotein cholesterol, triglyceride, albumin, high-sensitivity C-reactive-protein (hsCRP), eGFR (calculated).

Haematology: WBC, white blood cell; BASO, basophil; IG, immature granulocyte; NRBC, nucleated red blood cell; RET, reticulocyte; Ret-He, reticulocyte haemoglobin content; IRF/LRF/MRF/HRF immature, low, medium and high reticulocyte fraction; PLT, platelet (volume fraction); IPF, immature platelet fraction; PCT, platelet volume fraction; PDW, platelet volume difference (max-min); RBC, red blood cell; HGB, haemoglobin; HCT, haematocrit; MCV, mean corpuscular volume; MCHC, mean corpuscular haemoglobin concentration; RDW, red blood cell distribution; MPV, mean platelet volume; NEUT, neutrophil; LYMPH, lymphocyte; MONO, monocyte; EO, eosinophil.

Samples collected 2016 and 2017.

The 2 × 10 ml whole blood ethylene diamine tetra-acetate (EDTA) and 6 ml serum for biobank storage are spun and stored at 4ºC (±2ºC) overnight; transported refrigerated (4ºC ± 2ºC) to the biobank on the next morning; centrifuged; and aliquoted into 5 × 270 µl serum, 2 × 865 µl buffy coat, and 10 × 270 µl plasma using an automated system; and finally stored at −80ºC. Participants eligible for saliva collection should not have been eating, drinking, smoking, or using an inhalator or chewing gum for at least 60 minutes prior to collection. Saliva is collected after a maximum of 5 minutes of gum base stimulation. Urine (2 × 4 ml) and saliva (3 × 1.8 ml) for biobank storage are aliquoted into cryotubes and kept on dry ice immediately after collection and during transport until storage at −80ºC the same evening. Participants agreeing to contribute three tubes of faeces are instructed in the home procedure using a specialised toilet-insert to collect the faeces without contamination, and to keep the sealed samples in their own freezer until LOFUS staff pick it up later; the faecal samples are transported on dry ice and stored at −80ºC.

A full health examination including collection of and instruction for biological samples lasts on average 30 minutes per child \<15 years old, 50 minutes per person 15--50 years and 75 minutes per adult ⩾50 years.

Biobanks {#section12-1403494818799613}
--------

Blood samples are stored in the Region Zealand Biobank. Specimens of urine, saliva and faeces are stored at the biobank of the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, and additional urine samples are stored at the Department of Pharmacology, Rigshospitalet.

Database {#section13-1403494818799613}
--------

The LOFUS database uses MS SQL Server as the back-end data-storage, whereas the front-end user-interface is developed in MS Access. For proper protection of the participant-related data, the Access file contains no data. The database is used for both data storage and administrative management of the project, and it is stored on statutory logged drives. Only authorized personnel have access and all activity is logged. Completeness and correctness of datasets are controlled regularly.

Danish registries {#section14-1403494818799613}
-----------------

In Denmark, all individuals are designated a unique civil registration number at birth by the Danish Civil Registration System (CRS) \[[@bibr23-1403494818799613]\]. The number is used throughout life for healthcare, education, tax and employment purposes. The CRS also includes the name, gender, date of birth, place of birth, vital status (dead/alive), citizenship, identity of parents, spouses and place of residence. The CRS was initiated in 1968 and is continuously updated \[[@bibr23-1403494818799613]\]. The CRS is also linked to other registries, such as The Danish National Patient Register with information since 1977 \[[@bibr24-1403494818799613]\], The Danish Cancer Registry with information since 1943 \[[@bibr25-1403494818799613]\], and the Danish National Prescription Registry with information since 1994 \[[@bibr26-1403494818799613]\]. In LOFUS, individuals in both the invited and the control group are identified by their unique civil registration number, which allows linkage to and follow-up in Danish registers.

Return of results {#section15-1403494818799613}
-----------------

Abnormal findings at the health examination, e.g. severely low or high glucose level or severely abnormal electrocardiogram (ECG), are conferred immediately with the attending physician at the local hospital, who determines if hospitalization is needed or if the LOFUS participants should be recommended to contact their general practitioner (GP).

No later than 2 weeks after the health examination, the participants receive a letter with selected results of the health examination, e.g. blood pressure, lung function, haemoglobin and glycated haemoglobin A1c. Biochemical and physical measurements distinctly deviating from the reference range and elevated scores on the Major Depression Inventory \[[@bibr27-1403494818799613]\] or the Anxiety Symptom Scale (Danish: Angst-Symptom-Spørgeskemaet) \[[@bibr28-1403494818799613]\] trigger a recommendation for participants to consult their GP. For children, the content of the letter relies on the actual examinations they underwent, but height, weight and blood sugar are always included. All participants can check the full outcome of the biochemical analyses on their electronic health records on Sundhed.dk \[[@bibr29-1403494818799613]\].

'Grey-zone' ECGs are assessed by a cardiologist within a few days. If follow up is recommended, the participant is contacted and receives a copy of the ECG print, which is also sent to their GP. In addition, excess values on other biochemical measurements and/or burden of psychotic experiences are assessed individually.

Data analysis plan {#section16-1403494818799613}
------------------

The overall purpose of LOFUS is to identify associations between socioeconomic, genetic, lifestyle-related, familial and environmental factors and health. Currently, more than 15 sub-studies have been identified with specific analysis plans within genetics, microbiome, toxicology, internal medicine, gynaecology, geriatrics, physical activity, psychiatry, sociology and psychology. In addition, several other articles are planned. First, with use of Danish registries we will make a cross-sectional comparison of participating people with invited non-participants to investigate participation bias. Second, we will investigate the proportion of participants referred to the hospital or their GP in need of treatment for newly detected diseases or with treatment failure of prevalent diseases. Third, associations between reported lifestyle factors, or biochemical markers and health status will be searched for in the baseline data for participants. Fourth, participants, invited non-participants and the control group will be followed up in the national registers to identify associations between baseline characteristics and disease occurrence. A special emphasis will be given to identification of family clustered health problems and statistical tools for these analyses will be developed.

Governance {#section17-1403494818799613}
==========

A steering committee of researchers and administrators is responsible for the strategic, economic and operational decisions concerning the project. Members of the Danish scientific community assess protocols for sub-studies before approval by the steering committee. Sub-studies must adhere to the rules and regulations on research ethics and data protection. The LOFUS staff is employed at the Nykøbing Falster Hospital.

Ethics and dissemination {#section18-1403494818799613}
========================

Region Zealand's Ethical Committee on Health Research approved the study (SJ-421). The Danish Data Protection Agency approved the study (REG-24-2015). The study is registered in Clinical Trials (NCT02482896).

LOFUS uses two written consent forms: one for participants aged 0--14 years to be signed by the holders of custody and one for participants aged ⩾15 years. Both forms include a range of items that should be considered separately, e.g. storage of biological samples, genetic mapping and linkage to health registers and medical records. It is thus possible to opt in or out of selected parts.

Datasets for sub-studies are extracted without the civil registration numbers. If pseudo identification numbers are used, the link between these and the civil registration numbers is kept in a separate file. The LOFUS data will be deposited in the Danish Data Achieve after the data collection. Access to data will follow the rules of the archive \[[@bibr30-1403494818799613]\].

Results will be published in peer-reviewed, international and preferably open-access journals, listing authors according to authorship guidelines. Positive, negative and inconclusive results will be published.

Discussion {#section19-1403494818799613}
==========

The last 25 years of segregation in Denmark has resulted in employed people moving away from Lolland-Falster, and at the same time, unemployed people or people outside the labour market moving in \[[@bibr7-1403494818799613]\]. This segregation forms a challenge for the health status in Lolland-Falster in two ways. First, some of the newcomers are out of work for health reasons. Second, the decline in taxable income limits the possibilities for investments in preventive and health-promoting activities, such as better schools and daycare. In addition, Lolland-Falster faces challenges in recruiting medical doctors and other health professionals for both the primary and the secondary sector.

LOFUS was initiated to provide insight into the association between socioeconomic, genetic, lifestyle-related, familial and environmental factors and health in this disadvantaged area. The unique civil registration number \[[@bibr23-1403494818799613]\] links collected data for each participating individual, family and household, with information in Danish registers on vital status, socioeconomic status, diagnoses and use of healthcare. The broad range of collected data allows for linkage of, for instance, socioeconomic status, lifestyle and health status with microbiome data \[[@bibr31-1403494818799613],[@bibr32-1403494818799613]\]. A number of sub-studies already planned at the initiation of LOFUS are expected to provide new insights, e.g. Early ageing -- social causes behind frailty and loss of function; Psychiatric problems among children and young people; Personality, subjective well-being and health; Prevalence of metabolic syndrome in Lolland-Falster; Family function, cognitive function and health competences as determinants for mental and physical health. The project is open for other collaborators upon request. We expect the range of sub-studies to increase over the years.

Strengths and limitations {#section20-1403494818799613}
-------------------------

LOFUS is the only prospective cohort study of the rural population in Denmark. LOFUS is a useful scientific resource for investigating cross-sectional differences and time trends within and between individuals, families and households in all age groups. LOFUS adds diversity to the previously collected Danish general population studies, which have been collected in Copenhagen or other urbanized areas.

The extensive, and partly health-related, population movements \[[@bibr7-1403494818799613]\] in and out of Lolland-Falster complicates identification of causal relationships between health determinants and health. Both baseline and follow-up data will be influenced by the selection bias. Therefore, it is a strength that place of residence and employment history of the LOFUS participants can be retrieved from the Danish registers even before they were recruited to LOFUS.

The invitation procedure for LOFUS using a random selection of households via an index person ⩾18 years causes an overrepresentation of households with more than one person. However, sampling of households on a continuous basis was considered impossible. By linking to population registers, it will be possible to compare the constitution of participants with the non-participants, the uninvited control group and the entire Lolland-Falster population. As in other population studies, it is expected that non-participants will have lower socioeconomic status, more illnesses and lower mean survival than participants \[[@bibr33-1403494818799613],[@bibr34-1403494818799613]\].

To limit expenses and the duration of the health examination, the original protocol was modified such that measurement of ankle blood pressure and collection of faeces, saliva and urine samples for biobank storage were only performed from February 2016 to the end of 2017. Accelerometer-assessed physical activity was restricted to 2017 and 2018.

Perspectives {#section21-1403494818799613}
------------

Previous population-based health studies in Denmark have primarily focused on urbanized populations. This is the case for the Diet, Cancer and Health study recruiting participants from Copenhagen and Aarhus \[[@bibr16-1403494818799613]\], the Copenhagen City Heart Study \[[@bibr17-1403494818799613]\] and the Copenhagen General Population Study \[[@bibr19-1403494818799613]\]. To make research findings generalizable for the general public and use the results in public-health planning and precision medicine, these studies do not only need to be large, but also represent the underlying diversity in the population. LOFUS is an important addition as it focuses on a rural-provincial area with socioeconomic and health challenges. LOFUS forms the first possibility to learn about determinants of health in the disadvantaged areas of Denmark and will contribute to the international knowledge on health in rural-provincial areas. Comparison across Danish health studies can inform local and national politics.

The Copenhagen General Population Study \[[@bibr19-1403494818799613]\], the Danish General Suburban Population Study \[[@bibr18-1403494818799613]\] and LOFUS include similar datasets. Therefore, it will be possible to correlate the profiles of their measures and compare the morbidity and mortality of these respective populations. A previous comparison between the Copenhagen General Population Study and the Danish General Suburban Population Study showed that whereas 16% of the participants in the Copenhagen study were obese, this applies to 21% in the suburban population \[[@bibr18-1403494818799613]\]. With its higher mortality, the LOFUS population will add an extra dimension to these comparisons. Suggestions for predicting overall mortality based on data similar to those collected to these three Danish population studies have previously been reported based on United States data, e.g. the enhanced Intermountain Mortality Risk Score \[[@bibr35-1403494818799613]\] and the Health Status Metric \[[@bibr36-1403494818799613]\]. We plan to apply these United States suggestions to the Danish data.
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